Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 177

1.

Evaluation of the analgesic effect of 4-anilidopiperidine scaffold containing ureas and carbamates.

Monti L, Stefanucci A, Pieretti S, Marzoli F, Fidanza L, Mollica A, Mirzaie S, Carradori S, De Petrocellis L, Schiano Moriello A, Benyhe S, Zádor F, Szűcs E, Ötvös F, Erdei AI, Samavati R, Dvorácskó S, Tömböly C, Novellino E.

J Enzyme Inhib Med Chem. 2016 Apr 11:1-10. [Epub ahead of print]

PMID:
27063555
2.

Cell density dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-β in orbital fibroblasts.

Galgoczi E, Jeney F, Gazdag A, Erdei A, Katko M, M Nagy D, Ujhelyi B, Steiber Z, Gyory F, Berta E, Nagy EV.

J Endocrinol. 2016 Mar 15. pii: JOE-15-0524. [Epub ahead of print]

PMID:
26979769
3.

[Differential diagnosis of Graves' orbitopathy. Case report].

Erdei A, Steiber Z, Gazdag A, Bodor M, Berta E, Szász R, Szántó A, Ujhelyi B, Barna S, Berényi E, Nagy VE.

Orv Hetil. 2016 Feb 21;157(8):310-5. doi: 10.1556/650.2016.30381. Review. Hungarian.

PMID:
26876268
4.

Factor H inhibits complement activation induced by liposomal and micellar drugs and the therapeutic antibody rituximab in vitro.

Mészáros T, Csincsi ÁI, Uzonyi B, Hebecker M, Fülöp TG, Erdei A, Szebeni J, Józsi M.

Nanomedicine. 2016 May;12(4):1023-31. doi: 10.1016/j.nano.2015.11.019. Epub 2015 Dec 28.

PMID:
26733258
5.

Access Path to the Ligand Binding Pocket May Play a Role in Xenobiotics Selection by AhR.

Szöllősi D, Erdei Á, Gyimesi G, Magyar C, Hegedűs T.

PLoS One. 2016 Jan 4;11(1):e0146066. doi: 10.1371/journal.pone.0146066. eCollection 2016.

6.

Correction: Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro.

Varga A, Gyulavári P, Greff Z, Futosi K, Németh T, Simon-Szabó L, Kerekes K, Szántai-Kis C, Brauswetter D, Kokas M, Borbély G, Erdei A, Mócsai A, Kéri G, Vántus T.

PLoS One. 2015 Dec 16;10(12):e0144792. doi: 10.1371/journal.pone.0144792. eCollection 2015. No abstract available.

7.

Wavelength-dependent photooxidation and photoreduction of protochlorophyllide and protochlorophyll in the innermost leaves of cabbage (Brassica oleracea var. capitata L.).

Erdei AL, Kósa A, Kovács-Smirová L, Böddi B.

Photosynth Res. 2016 Apr;128(1):73-83. doi: 10.1007/s11120-015-0200-3. Epub 2015 Oct 30.

PMID:
26519365
8.
9.

Secreted aspartic protease 2 of Candida albicans inactivates factor H and the macrophage factor H-receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18).

Svoboda E, Schneider AE, Sándor N, Lermann U, Staib P, Kremlitzka M, Bajtay Z, Barz D, Erdei A, Józsi M.

Immunol Lett. 2015 Nov;168(1):13-21. doi: 10.1016/j.imlet.2015.08.009. Epub 2015 Aug 22.

PMID:
26306739
10.

Targeting vascular endothelial growth factor receptor 2 and protein kinase D1 related pathways by a multiple kinase inhibitor in angiogenesis and inflammation related processes in vitro.

Varga A, Gyulavári P, Greff Z, Futosi K, Németh T, Simon-Szabó L, Kerekes K, Szántai-Kis C, Brauswetter D, Kokas M, Borbély G, Erdei A, Mócsai A, Kéri G, Vántus T.

PLoS One. 2015 Apr 14;10(4):e0124234. doi: 10.1371/journal.pone.0124234. eCollection 2015. Erratum in: PLoS One. 2015;10(12):e0144792.

11.

Complement receptor type 1 (CR1/CD35) expressed on activated human CD4+ T cells contributes to generation of regulatory T cells.

Török K, Dezső B, Bencsik A, Uzonyi B, Erdei A.

Immunol Lett. 2015 Apr;164(2):117-24. doi: 10.1016/j.imlet.2015.02.009. Epub 2015 Mar 2. Erratum in: Immunol Lett. 2015 Oct;167(2):155.

PMID:
25742728
12.

Syk is indispensable for CpG-induced activation and differentiation of human B cells.

Kremlitzka M, Mácsik-Valent B, Erdei A.

Cell Mol Life Sci. 2015 Jun;72(11):2223-36. doi: 10.1007/s00018-014-1806-x. Epub 2014 Dec 28.

PMID:
25543269
13.

Single cell adhesion assay using computer controlled micropipette.

Salánki R, Hős C, Orgovan N, Péter B, Sándor N, Bajtay Z, Erdei A, Horvath R, Szabó B.

PLoS One. 2014 Oct 24;9(10):e111450. doi: 10.1371/journal.pone.0111450. eCollection 2014.

14.

Pseudopheochromocytoma induced by anxiolytic withdrawal.

Páll A, Becs G, Erdei A, Sira L, Czifra A, Barna S, Kovács P, Páll D, Pfliegler G, Paragh G, Szabó Z.

Eur J Med Res. 2014 Oct 8;19:53. doi: 10.1186/s40001-014-0053-9.

15.

Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer.

Gazdag A, Nagy EV, Erdei A, Bodor M, Berta E, Szabó Z, Jenei Z.

J Endocrinol Invest. 2015 Feb;38(2):133-42. doi: 10.1007/s40618-014-0143-0. Epub 2014 Sep 7.

PMID:
25194423
16.

[Novel treatment opportunities in Graves' orbitopathy].

Erdei A, Gazdag A, Bodor M, Berta E, Katkó M, Ujhelyi B, Steiber Z, Győry F, Urbancsek H, Barna S, Galuska L, Nagy VE.

Orv Hetil. 2014 Aug 17;155(33):1295-300. doi: 10.1556/OH.2014.29963. Review. Hungarian.

PMID:
25109914
17.

Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves' orbitopathy: A five-year follow-up study.

Erdei A, Paragh G, Kovacs P, Karanyi Z, Berenyi E, Galuska L, Lenkey A, Szabados L, Gyory F, Ujhelyi B, Berta A, Boda J, Berta E, Bodor M, Gazdag A, Nagy EV.

Autoimmunity. 2014 Dec;47(8):548-55. doi: 10.3109/08916934.2014.939266. Epub 2014 Jul 21.

PMID:
25039242
18.

Immunology Letters. IMmune-related Pathologies: Understanding Leukocyte Signaling and Emerging Therapies--IMPULSE 2013. Introduction.

Erdei A, Sármay G, Matkó J, Prechl J.

Immunol Lett. 2014 Aug;160(2):107-8. doi: 10.1016/j.imlet.2014.04.001. Epub 2014 Apr 8. No abstract available.

PMID:
24721899
19.

Volatile glycosides from the leaves of Morus alba with a potential contribution to the complex anti-diabetic activity.

Hunyadi A, Herke I, Veres K, Erdei A, Simon A, Tóthb G.

Nat Prod Commun. 2014 Feb;9(2):145-7.

PMID:
24689274
20.

EFIS: driving women's representation in immunology in Europe.

Sautés-Fridman C, Erdei A.

Eur J Immunol. 2014 Mar;44(3):615. doi: 10.1002/eji.201470026. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk